Detalhe da pesquisa
1.
Comprehensive profiling of clinical JAK inhibitors in myeloproliferative neoplasms.
Am J Hematol
; 98(7): 1029-1042, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37203407
2.
Mouse lysine catabolism to aminoadipate occurs primarily through the saccharopine pathway; implications for pyridoxine dependent epilepsy (PDE).
Biochim Biophys Acta Mol Basis Dis
; 1863(1): 121-128, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27615426
3.
Altered erythropoiesis via JAK2 and ASXL1 mutations in myeloproliferative neoplasms.
Exp Hematol
; 132: 104178, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38340948
4.
DNA damage, demethylation and anticancer activity of DNA methyltransferase (DNMT) inhibitors.
Sci Rep
; 13(1): 5964, 2023 04 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37045940
5.
Complementary and countervailing actions of Jak2 and Ikk2 in hematopoiesis in mice.
Exp Hematol
; 128: 48-66, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37611729
6.
DUSP6 mediates resistance to JAK2 inhibition and drives leukemic progression.
Nat Cancer
; 4(1): 108-127, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36581736
7.
Pevonedistat targets malignant cells in myeloproliferative neoplasms in vitro and in vivo via NFκB pathway inhibition.
Blood Adv
; 6(2): 611-623, 2022 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34644371
8.
Low-dose methotrexate in sickle-cell disease: a pilot study with rationale borrowed from rheumatoid arthritis.
Exp Hematol Oncol
; 6: 18, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28638723
9.
Therapeutic target discovery and drug development in cancer stem cells for leukemia and lymphoma: from bench to the clinic.
Expert Opin Drug Discov
; 11(11): 1071-1080, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27626707
10.
Simultaneous detection of lysine metabolites by a single LC-MS/MS method: monitoring lysine degradation in mouse plasma.
Springerplus
; 5: 172, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27026869
11.
N-(1'-naphthyl)-3,4,5-trimethoxybenzohydrazide as microtubule destabilizer: Synthesis, cytotoxicity, inhibition of cell migration and in vivo activity against acute lymphoblastic leukemia.
Eur J Med Chem
; 96: 504-18, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25951294
12.
IL-7 contributes to the progression of human T-cell acute lymphoblastic leukemias.
Cancer Res
; 71(14): 4780-9, 2011 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21593192